entertainment -WSS

entertainment

author：leisure time 2025-10-01 17:34:09 - browse：1

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： A new drug could help frostbite victims avoid its ravages

WSS

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Diabetes management: Digital health tools fall short, study says

New study raises questions about niacin and heart health

Pregnancy ages women, but effects reverse after delivery

Diabetes management: Digital health tools fall short, study says

Steward Health Care expansion into Malta flopped

focus

entertainment

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Drug repurposing or repositioning? The language matters

Steward Health Care expansion into Malta flopped

23andMe had bad news about my health. I wish a person had delivered it

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Guidelines to prevent youth baseball injuries need more muscle

Biotech investment managers search for lucrative opportunities

Psychedelics group wrestles with new pharma identity

Medicare Advantage insurers pressure Biden for bigger payments

hotspot

Medicare Advantage insurers pressure Biden for bigger payments

This gene therapy has record $4.25 million price. It's saved children.

Readout Newsletter: Illumina, CRISPR, Regeneron

Medicare Advantage insurers pressure Biden for bigger payments

Flagship Pioneering startup Sonata Therapeutics lays off 21

As AI regulations shape up, health tech startups beg for clarity

explore

knowledge

explore

leisure time